Stay updated on Pediatric Tesevatinib Safety in ARPKD Clinical Trial
Sign up to get notified when there's something new on the Pediatric Tesevatinib Safety in ARPKD Clinical Trial page.

Latest updates to the Pediatric Tesevatinib Safety in ARPKD Clinical Trial page
- Check4 days agoChange DetectedRecord history shows the latest revision listed as v3.6.3, replacing the prior v3.6.2. This reflects a minor update to the page's release notes rather than substantive changes to study content.SummaryDifference0.1%

- Check11 days agoChange DetectedA new Revision: v3.6.2 entry was added to the study record history, replacing the previous Revision: v3.6.0. This reflects a lightweight release-note update to the page rather than changes to the study data or core content.SummaryDifference0.1%

- Check18 days agoNo Change Detected
- Check25 days agoChange DetectedRecruitment status shows no longer looking for participants. The history also adds Revision: v3.6.0 and removes Revision: v3.5.5 to update the record's version history.SummaryDifference0.4%

- Check32 days agoChange DetectedA new revision entry v3.5.5 was added to the record history. The previous revision v3.5.4 was removed from the history.SummaryDifference0.1%

- Check54 days agoChange DetectedThe revision history now shows v3.5.4 as the latest version, replacing the prior v3.5.3 entry.SummaryDifference0.1%

- Check68 days agoChange DetectedThe footer now displays a new revision label v3.5.3, replacing the previous v3.5.2, indicating a site release.SummaryDifference0.1%

Stay in the know with updates to Pediatric Tesevatinib Safety in ARPKD Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Pediatric Tesevatinib Safety in ARPKD Clinical Trial page.